ArticleSoftware impacts2022
ModInterv: An automated online software for modeling epidemics.
Article in Software impacts, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluating information management system in epidemic infectious diseases in Iran.Scientific reports · 2024Article
- ModInterv COVID-19: An online platform to monitor the evolution of epidemic curves.Applied soft computing · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has proven the importance of mathematical tools to understand the evolution of epidemic outbreaks and provide reliable information to the general public and health authorities. In this perspective, we have developed ModInterv, an online software that applies growth models to monitor the evolution of the COVID-19 epidemic in locations chosen by the user among countries worldwide or states and cities in the USA or Brazil. This paper describes the software capabilities and its use both in recent research works and by technical committees assisting government authorities. Possible applications to other epidemics are also briefly discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.